Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Understanding Diagnostic Delays for Kaposi Sarcoma in Kenya: A Qualitative Study

Domaine:

healthcare
Créateur:
DevLinMerRhe
Éditeur:
Ovi
Hôte:
Background: Although HIV-associated Kaposi sarcoma (KS) is frequently diagnosed at an advanced stage in sub-Saharan Africa, reasons for diagnostic delays have not been well described. Methods: We enrolled patients >18 years with newly diagnosed KS between 2016 and 2019 into the parent study, based in western Kenya. We then purposively selected 30 participants with diversity of disease severity and geographic locations to participate in semistructured interviews. We used 2 behavioral models in developing the codebook for this analysis: situated Information, Motivation, and Behavior framework and Andersen model of total patient delay. We then analyzed the interviews using framework analysis. Results: The most common patient factors that delayed diagnosis were lack of KS awareness, seeking traditional treatments, lack of personal efficacy, lack of social support, and fear of cancer, skin biopsy, amputation, and HIV diagnosis. Health system factors that delayed diagnosis included previous negative health care interactions, incorrect diagnoses, lack of physical examination, delayed referral, and lack of tissue biopsy availability. Financial constraints were prominent barriers for patients to access and receive care. Facilitators for diagnosis included being part of an HIV care network, living near health facilities, trust in the health care system, desire to treat painful or disfiguring lesions, and social support. Conclusions: Lack of KS awareness among patients and providers, stigma surrounding diagnoses, and health system referral delays were barriers in reaching KS diagnosis. Improved public health campaigns, increased availability of biopsy and pathology facilities, and health provider training about KS are needed to improve early diagnosis of KS.

Visit

doi.org

Similaires

Risk factors for kaposi sarcoma-associated herpesvirus (KSHV) and kaposi sarcoma (KS) mortality in sub-Saharan Africa, ThePrognosis, diagnostic delay, and patient characteristics associated with diagnostic delay among Kaposi sarcoma (KS) patients in Uganda.End-user perspectives on design and implementation of a novel SkinScan3D (SS3D) device for monitoring Kaposi Sarcoma in East Africa: a qualitative studyAdmitted AIDS-associated Kaposi sarcoma patientsLong‐term outcomes for children and adolescents with Kaposi sarcomaA prospective study of clinical outcomes of HIV-associated and HIV-negative Kaposi sarcoma in Uganda

Risk factors for kaposi sarcoma-associated herpesvirus (KSHV) and kaposi sarcoma (KS) mortality in sub-Saharan Africa, The

The largest worldwide burden of Kaposi sarcoma (KS), 85% of all cases, is found in sub-Saharan Afric

Prognosis, diagnostic delay, and patient characteristics associated with diagnostic delay among Kaposi sarcoma (KS) patients in Uganda.

6578 Background: The incidence and mortality of KS remain high in sub-Saharan Africa. Delaying tr

End-user perspectives on design and implementation of a novel SkinScan3D (SS3D) device for monitoring Kaposi Sarcoma in East Africa: a qualitative study

Introduction: SkinScan3D (SS3D) is a novel, artificial intelligence-enabled device that provides obj

Admitted AIDS-associated Kaposi sarcoma patients

Abstract Kaposi sarcoma (KS) is an AIDS-defining angioproliferative malignancy associa

Long‐term outcomes for children and adolescents with Kaposi sarcoma

Abstract Objectives Kaposi sarcoma (KS) is one of the most common childhood cancers in eastern an

A prospective study of clinical outcomes of HIV-associated and HIV-negative Kaposi sarcoma in Uganda

Objective: Improved understanding of the effect of HIV infection on Kaposi sarcoma (KS